Pawlik et al. analyzing -174G/C IL-6 gene promoter polymorphism in RA patients identified that genotype GG may confer a risk for lower response to MTX compared with genotypes GC and CC [20]. This evidence concerns the gene IL6 and rheumatoid arthritis.